Regular Article
Bacterial Lipopolysaccharide Increases Prostaglandin Production by Rat Astrocytes via Inducible Cyclo-oxygenase: Evidence for the Involvement of Nuclear Factor κB

https://doi.org/10.1006/bbrc.1999.1413Get rights and content

Abstract

This study was set to investigate the mechanisms through which bacterial lipopolysaccharide (LPS) stimulates prostaglandin (PG) production in rat astrocytes. Primary cultures of rat hypothalamic astrocytes were established. Cells were treated with LPS alone or LPS plus antagonists of various pathways, and the subsequent changes in cyclo-oxygenase (COX) activity were monitored by measuring a COX end product, PGE2, released into the incubation medium. It was found that (i) LPS produced a concentration-dependent increase in PGE2 release from astrocytes. The potency of LPS was significantly increased by the addition of serum into the incubation medium; (ii) after 24 h of incubation, inducible COX (COX-2) accounts for most of the LPS-stimulated PG production, as the latter was markedly reduced by dexamethasone and the specific COX-2 inhibitor NS 398; and (iii) nuclear factor κB appears to play a role in the activation of COX-2 induced by LPS, since certain inhibitors of this transcription factor were able to antagonize, at least in part, the effects of LPS on PGE2 release.

References (24)

  • K. Yamagata et al.

    Neuron

    (1993)
  • P.L. McGeer et al.

    Brain Res. Rev.

    (1995)
  • G. Pistritto et al.

    Neurosci. Lett.

    (1998)
  • N. Futaki et al.

    Prostaglandins

    (1994)
  • J.-P. Yang et al.

    FEBS Lett.

    (1995)
  • E. Galea et al.

    J. Neuroimmunol.

    (1996)
  • T. Nakano et al.

    J. Biol. Chem.

    (1990)
  • T. Tetsuka et al.

    J. Biol. Chem.

    (1996)
  • C.D. Breder et al.

    J. Comp. Neurol.

    (1995)
  • C.D. Breder et al.

    J. Comp. Neurol.

    (1992)
  • G.P. O'Neill et al.

    FEBS Lett.

    (1993)
  • Cited by (46)

    • Interaction between the carbon monoxide and nitric oxide pathways in the locus coeruleus during fever

      2012, Neuroscience
      Citation Excerpt :

      Specifically in the preoptic area of the hypothalamus, where sGC levels are low (Mancuso et al., 1998), NO (Steiner et al., 2002), but not CO (Steiner and Branco, 2002; Maines, 1997), seems to stimulate cGMP synthesis. Nonetheless, CO has been shown to participate in hypothalamic functions through cyclooxygenase (COX) activation (Mancuso et al., 1997, 2006; Errico et al., 2010), being both constitutive and inducible COX activities upregulated in hypothalamic cells (Pistritto et al., 1998, 1999). Moreover, it has been documented that the HO/CO pathway in the hypothalamus plays an inhibitory role in LPS-induced release of vasopressin (Mancuso et al., 1999), reinforcing the idea of a brain area-specific effect of the HO/CO system on stress responses.

    • Hydrogen sulfide as a cryogenic mediator of hypoxia-induced anapyrexia

      2012, Neuroscience
      Citation Excerpt :

      Actually, we have previously suggested a thermoregulatory model in which key molecules acting in the AVPO may cause increases or decreases in thermoregulatory set point (Steiner et al., 2002a). Since the generation of prostaglandins, particularly by hypothalamic nervous cells (Pistritto et al., 1998, 1999), is known to elevate Tb, it is an interesting hypothesis that H2S production is reduced during febrile response and H2S modulates cyclooxygenase activity. The cyclic nucleotide cAMP is a second messenger that produces most of its effects by activating cAMP-dependent protein kinase (protein kinase A, PKA).

    • Phosphatidic acid phosphohydrolase in the regulation of inflammatory signaling

      2009, Advances in Enzyme Regulation
      Citation Excerpt :

      Collectively, these published reports suggest that PLD and PAP-1 participate together in the activation of the inflammatory GIVA PLA2, at least in some cellular systems. Biochemical and genetic approaches have demonstrated that LPS stimulation of TLR-4 results in the NF-κB-mediated upregulation of COX-2 (Liu et al., 1999; Kojima et al., 2000; Caivano and Cohen, 2000; Pistritto et al., 1999; Lo et al., 1998). PKC is known to participate in NF-κB-mediated COX-2 expression in the TLR-4 pathway by phosphorylating I-κB as well as targeting MAPK (Lin and Chen, 1999; Wang and Smart, 1999; Giroux and Descoteaux, 2000; Chiang et al., 2003; Peng et al., 2008).

    • Inhibition of lymphocyte CD3 expression by Chlamydophila pneumoniae infection

      2008, Microbial Pathogenesis
      Citation Excerpt :

      Cyclooxygenase-2 (Cox-2), known as prostaglandin-endoperoxide synthase, is the key enzyme in biosynthesis of prostanoids such as prostaglandins, prostacyclin and thromboxanase [22–25]. Since the expression of Cox-2, which is eicosanoid precursor, is induced by LPS, growth factors and cytokines [26–28], this increasing may be involved in the modulation of inflammatory responses. It has also been shown that there is the augmented expression of eicosanoid precursor Cox-2 in monocyte-drived macrophages of atheromatous lesions but not in healthy arteries and enhanced expression of Cox-2 may be importance for atherogenesis [22].

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at Institute of Pharmacology, Catholic University Medical School, Largo Francesco Vito 1-00168 Rome, Italy. Fax: +39 6 3050159. E-mail: [email protected].

    View full text